Chemed (CHE) EBT (2009 - 2026)

Chemed (CHE) has reported EBT for 18 consecutive years, with $88.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, EBT fell 7.14% year-over-year to $88.8 million; the TTM figure through Mar 2026 stood at $348.9 million (down 15.03% YoY), while the FY2025 annual figure was $355.8 million, down 10.94% from the prior year.
• EBT came in at $88.8 million for Q1 2026 at Chemed, down from $105.4 million in the prior quarter.
• The five-year high for EBT was $120.1 million in Q4 2024, with the low at $70.3 million in Q2 2023.
• Average EBT over 5 years is $89.7 million, with a median of $86.1 million recorded in 2022.
• Across the five-year window, EBT surged 40.28% in 2023 and slipped 24.21% in 2025, its largest moves.
• Year by year, EBT stood at $82.4 million in 2022, then surged by 40.28% to $115.6 million in 2023, then gained by 3.92% to $120.1 million in 2024, then declined by 12.22% to $105.4 million in 2025, then dropped by 15.75% to $88.8 million in 2026.
• According to Business Quant data, EBT over the past three periods registered $88.8 million, $105.4 million, and $83.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.